These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2939040)
1. Generation of suppressor cells in normal rats by treatment with spirogermanium, a novel heterocyclic anticancer drug. Badger AM; Mirabelli CK; DiMartino M Immunopharmacology; 1985 Dec; 10(3):201-7. PubMed ID: 2939040 [TBL] [Abstract][Full Text] [Related]
2. Antiarthritic and immunoregulatory activity of spirogermanium. DiMartino MJ; Lee JC; Badger AM; Muirhead KA; Mirabelli CK; Hanna N J Pharmacol Exp Ther; 1986 Jan; 236(1):103-10. PubMed ID: 2934544 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of autoimmune disease and the generation of suppressor cells by spirogermanium: a biological profile similar to total lymphoid irradiation. Badger AM; Mirabelli CK; Swift BA; DiMartino MJ Agents Actions; 1989 Jun; 27(3-4):335-7. PubMed ID: 2529742 [TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory activity and non-specific suppressor cell generation by spirogermanium in murine and rat models of cell-mediated immunity. Badger AM; DiMartino MJ; Swift BA; Mirabelli CK Immunopharmacology; 1988; 16(1):33-43. PubMed ID: 2971635 [TBL] [Abstract][Full Text] [Related]
5. Suppressor cell induction by the anticancer drug spirogermanium. Badger AM; DiMartino MJ; Schmitt TC; Swift BA; Mirabelli CK Int J Immunopharmacol; 1987; 9(5):621-30. PubMed ID: 2957334 [TBL] [Abstract][Full Text] [Related]
6. Spirogermanium: a new investigational drug of novel structure and lack of bone marrow toxicity. Slavik M; Blanc O; Davis J Invest New Drugs; 1983; 1(3):225-34. PubMed ID: 6678870 [TBL] [Abstract][Full Text] [Related]
7. Antiarthritic and suppressor cell inducing activity of azaspiranes: structure-function relationships of a novel class of immunomodulatory agents. Badger AM; Schwartz DA; Picker DH; Dorman JW; Bradley FC; Cheeseman EN; DiMartino MJ; Hanna N; Mirabelli CK J Med Chem; 1990 Nov; 33(11):2963-70. PubMed ID: 2146392 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effects and biological activity of 2-aza-8-germanspiro[4,5]-decane-2-propanamine-8,8-diethyl-N,N-dimethyl dichloride (NSC 192965; spirogermanium) in vitro. Hill BT; Whatley SA; Bellamy AS; Jenkins LY; Whelan RD Cancer Res; 1982 Jul; 42(7):2852-6. PubMed ID: 7200828 [TBL] [Abstract][Full Text] [Related]
9. Spirogermanium: a new drug with antimalarial activity against chloroquine-resistant Plasmodium falciparum. Mrema JE; Slavik M; Davis J Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):167-71. PubMed ID: 6345410 [TBL] [Abstract][Full Text] [Related]
11. Induction of non-specific suppressor cells in normal Lewis rats by a novel azaspirane SK&F 105685. Badger AM; King AG; Talmadge JE; Schwartz DA; Picker DH; Mirabelli CK; Hanna N J Autoimmun; 1990 Aug; 3(4):485-500. PubMed ID: 2145847 [TBL] [Abstract][Full Text] [Related]
12. Preliminary study on the suppression of experimental autoimmune encephalomyelitis in the Lewis rat with spirogermanium. Sacks HJ; Braunstein V; Brosnan CF J Neuropathol Exp Neurol; 1987 May; 46(3):250-61. PubMed ID: 3494106 [TBL] [Abstract][Full Text] [Related]
13. Decreased T-suppressor cell activity in rats with adjuvant arthritis. Binderup L Ann Rheum Dis; 1983 Dec; 42(6):693-8. PubMed ID: 6228200 [TBL] [Abstract][Full Text] [Related]
14. Spirogermanium: effects on hematopoietic stem cells and survival of normal and tumor-bearing mice. Schwartz GN; Biegel JA; Fisher B; Klein I Proc Soc Exp Biol Med; 1983 Jun; 173(2):176-80. PubMed ID: 6866997 [TBL] [Abstract][Full Text] [Related]
15. Lymphocyte-macrophage co-operation during induction of T-suppressor cell activity in rats with adjuvant arthritis. Binderup L Ann Rheum Dis; 1983 Dec; 42(6):687-92. PubMed ID: 6228199 [TBL] [Abstract][Full Text] [Related]
16. Suppression of adjuvant arthritis in rats by transfer of cultured spleen cells. Ogawa H; Tsunematsu T Clin Exp Immunol; 1986 Apr; 64(1):88-93. PubMed ID: 2942324 [TBL] [Abstract][Full Text] [Related]
17. The effect of SK&F 105685, a novel suppressor cell-inducing compound, in the adjuvant arthritic rat. Badger AM; Swift BA; Bugelski PJ; High WB; DiMartino MJ; Greig R Br J Rheumatol; 1991; 30 Suppl 2():66-9. PubMed ID: 1825183 [No Abstract] [Full Text] [Related]
18. Pharmacological activities of spirogermanium and other structurally related azaspiranes: effects on tumor cell and macrophage functions. Mirabelli CK; Badger AM; Sung CP; Hillegass L; Sung CM; Johnson RK; Picker D; Schwartz D; Dorman J; Martellucci S Anticancer Drug Des; 1989 Mar; 3(4):231-42. PubMed ID: 2930625 [TBL] [Abstract][Full Text] [Related]
19. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides. Raziuddin S; Kibler RF; Morrison DC J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621 [TBL] [Abstract][Full Text] [Related]
20. Effects of a novel azaspirane (SK&F 105685) on arthritic lesions in the adjuvant Lewis rat: attenuation of the inflammatory process and preservation of skeletal integrity. High WB; Bugelski PJ; Nichols ME; Swift BA; Solleveld HA; Badger AM J Rheumatol; 1994 Mar; 21(3):476-83. PubMed ID: 8006892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]